MyChesCo on MSN14 天
Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease
Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for ...
Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or ...
Endo, Inc.: Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern ...
Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) in patients with Peyronie's disease (PD) ...